The relationship between ankle-brachial index (ABI) remains uncertain relative to clinical and angiographic features of critical limb ischemia (CLI). From July 2011 to February 2013, 89 consecutive patients with CLI had non-invasive testing for indications of rest pain (n=23, 26%), as well as minor (n=29, 33%) and major (n=37, 42%) ischemic tissue loss. All patients subsequently underwent ABI testing and lower extremity angiography with visualization of the infragenicular arteries. Toe-brachial index (TBI) testing was available among 31 of these patients. Among patients with any ischemic tissue loss, 29% had an ABI between 0.7 and 1.4. Patients with rest pain alone had reduced odds of abnormal arterial runoff in univariate (OR 0.75, 95% CI 0.63-0.90; p=0.002) but not multivariate (p=0.50) analysis. Advanced age, increased ABI, reduced creatinine clearance, hyperlipidemia, and prior coronary artery disease were predictive of abnormal infragenicular runoff. Despite limitations in statistical power, median TBI, compared to ABI, tended to increase when infragenicular arterial runoff was preserved. Overall, the association of TBI with abnormal runoff was not significant (p=0.38). In conclusion, in the evaluation of CLI, nearly one-third of patients with any ischemic tissue loss had a normal or mildly reduced ABI. Assessment of TBI may augment the diagnostic accuracy of ABI in the evaluation of CLI.

No abstract

Background: Cardiac manifestations in COVID-19 are multifactorial and are associated with increased mortality. The clinical utility and prognostic value of echocardiography in COVID-19 inpatients is not clearly defined. We aim to identify echocardiographic parameters that are associated with 30-day clinical outcomes secondary to COVID-19 hospitalization. Methods: This retrospective cohort study was conducted in a large tertiary hospital in New York City during the COVID-19 pandemic. It included 214 adult inpatients with a laboratory confirmed diagnosis of COVID-19 by reverse transcriptase polymerase chain reaction assay (RT-PCR) for SARS-CoV-2 on nasopharyngeal swab and had a transthoracic echocardiogram performed during the index hospitalization. Primary outcome was 30-day all-cause inpatient mortality. Secondary outcomes were 30-day utilization of mechanical ventilator support, vasopressors, or renal replacement therapy. Results: Mild right ventricular systolic dysfunction [OR:3.51, 95% CI:1.63–7.57, p=0.001], moderate to severe right ventricular systolic dysfunction [OR:7.30, 95% CI:2.20–24.25, p=0.001], pulmonary hypertension [OR:5.39, 95% CI:1.96–14.86, p=0.001], and moderate to severe tricuspid regurgitation [OR:3.92, 95% CI:1.71–9.03, p=0.001] were each associated with increased odds of 30-day all-cause inpatient mortality. Pulmonary hypertension and moderate to severe right ventricular dysfunction were each associated with increased odds of 30-day utilization of mechanical ventilator support and vasopressors. Conclusions: Right ventricular dysfunction, pulmonary hypertension, and moderate to severe tricuspid regurgitation were associated with increased odds for 30-day inpatient mortality. This study highlights the importance of echocardiography and its clinical utility and prognostic value for evaluating hospitalized COVID-19 patients.

Cerebral angiography is an invasive procedure utilized without supporting guidelines in preoperative evaluations of infective endocarditis (IE). It is used to identify mycotic intracranial aneurysm, which is suspected to increase the risk of intracranial bleeding during cardiac surgery. Our objectives were to: (1) assess the utility of cerebral angiography by determining which subset of IE patients benefit from its performance; and (2) identify clinical and noninvasive screening tests that can preclude the need for invasive cerebral angiography. Retrospective analysis was performed of all patients treated surgically for IE from 7/2007 to 1/2012 and discharged with medical treatment for IE from 7/2007 to 7/2009 presenting to a large academic center. Of the 151 patients who underwent cerebral angiography, mycotic aneurysm was identified in seven (prevalence=4.6%; 95% CI 2.3-9.3%). Five had viridans group streptococci as the causative IE microorganism (p=0.0017). Noninvasive imaging and particularly absence of intracranial bleed on magnetic resonance imaging conveys a negative predictive value (NPV) of 0.977 (95% CI 0.879-0.996). Absence of a focal neurologic deficit or altered mental status convey a NPV of 0.990 (95% CI 0.945-0.998) and 0.944 (95% CI 0.883-0.974), respectively. Clinical suspicion for mycotic aneurysm and thus utilization of cerebral angiography is likely necessary only in the setting of acute neurologic deficits and when noninvasive imaging demonstrates acute intracranial bleed. A novel association between viridans group streptococci and intracranial mycotic aneurysm is demonstrated.

Society of Cardiology have established benchmarks for patient transfer times (door-in-door-out time and door-toballoon time) that serve as clinical performance measures for ST-segment-elevation myocardial infarction (STEMI) networks. Campaigns, such as D2B Alliance and Mission Lifeline, were also launched in an effort to reduce system delays in transfer and improve outcomes for subjects presenting with STEMI.1 This scrutiny on pre-and interhospital care has led to marked reductions in door-to-balloon times across the United States. 2Unlike STEMI, acute aortic syndrome (AAS) defined as acute aortic dissection, intramural hematoma, or penetrating aortic ulcer is a less frequent clinical event that lacks an effective diagnostic biomarker and requires definitive imaging for confirmation. The time-sensitive nature of AAS, complexity of surgery, and endovascular intervention and the relative paucity of institutions that deliver 24/7 state-of-the-art care strongly advocates for regional systems of care across the United States. Successful transfer of patients with AAS has previously been described through such efficient regional care models.3,4 Our aim was to evaluate safety and timeliness of transfer provided by our regional aortic network. The transfer metrics served by this analysis will help us improve as a network and more importantly serve as a benchmark to be replicated and improved on by others. Methods and ResultsOur AAS network shares a common hotline with our STEMI and stroke networks. On activation, a transfer team is dispatched immediately to the referring center. The transfer system is operated by critical care trained nurse practitioners and paramedics, who are equipped in handling all cardiovascular emergencies under direct consultation with cardiac intensive care unit (CCU) physicians. The transfer team's goal is to expedite safe transfer and optimize medical care during transfer for these patients. Transfer times were abstracted on consecutive patients transported with suspected AAS between March 2010 and May 2013. We defined total transfer time (TTT) as time from activation of AAS network to patient arrival at aortic center CCU and handover time (HT) as time from arrival of our transfer team at referring hospital to dispatch toward the tertiary center.A total of 359 patients were transferred from 84 different regional medical centers in the given time frame. Mean age was 65 years and 58% were men. Transfers were accomplished by the institutional critical care transfer system using ground ambulance (n=83), helicopter (n=248), or fixed-wing jet (n=28) from referring centers directly to our CCU bypassing the emergency department. Comprehensive TTT and HT data were available for 307 patients. Median transfer distance was 66 km (interquartile range, 23-117), and median TTT was 88 minutes (interquartile range, 67-117). More than 3 quarters (76%; n=234/307) of the patients were successfully transferred to the CCU within 2 hours of network activation ( Figure 1A). Median HT was 35 minutes (interquartile rang...

No abstract

No abstract

No abstract